Health & Medicine · Oncology
EACR Cancer Biology: Virtual Systems & Beyond
Part of the EACR Cancer Biology: Virtual Systems & Beyond series →

About & call for papers
Computational models are becoming part of how cancer is studied, alongside laboratory and clinical work. AI methods, including foundation/generative models, are starting to capture aspects of the molecular and spatial organisation of tumours from large, multim… Read more
Computational models are becoming part of how cancer is studied, alongside laboratory and clinical work. AI methods, including foundation/generative models, are starting to capture aspects of the molecular and spatial organisation of tumours from large, multimodal datasets. Efforts to simulate how tumours respond to perturbation and to predict individual patient outcomes are active but harder, and results haven’t yet been shown to hold at the scale and reliability that clinical use requires. Validation, generalisation across cohorts, interpretability, and integration with experiments and trials remain open problems.
This conference will bring together computational and experimental scientists and clinicians to assess what current models can and cannot do, where they add value in discovery and care, and what’s needed to move from representation toward reliable simulation and prediction. The goal is a realistic account of where these approaches help, where they fall short, and what comes next.
The target audience for this conference is basic, computational, and translational cancer scientists, clinicians, and machine learning researchers, both senior and early-career, from academia and industry, who want a broad overview of computational modelling, AI, and virtual systems in cancer biology and their translation to the clinic.
Speakers: Raza Ali (CRUK Cambridge Institute, UK) | Hana Aliee (CRUK Cambridge Institute, UK) | Charlotte Bunne (EPFL, Switzerland) | Mireia Crispin-Ortuzar (University of Cambridge, UK) | Trey Ideker (University of Oxford Big Data Institute, UK) | Mingyao Li (Perelman School of Medicine, USA) | Mo Lotfollahi (Wellcome Sanger Institute, UK) | Lichun Ma (NCI, NIH, USA) | Mor Nitzan (The Hebrew University of Jerusalem, Israel) | Marianna Rapsomaniki (Swiss Biomedical Data Science Center, Switzerland) | Eytan Ruppin (Cedars Sinai, USA) | Ewa Szczurek (University of Warsaw, Poland) | Aristoltelis Tsirigos (NYU School of Medicine, USA) | Sophia J Wagner (Heidelberg University, Germany) | Linghua Wang (UT MD Anderson, USA)
Keywords: cancer research, oncology, cancer biology, computational cancer models, scalable cancer models, AI, machine learning, foundation models, generative models, mapping molecular organisation, mapping spatial organisation, multimodal datasets, single-cell omics, spatial omics, digital pathology, histology, precision oncology, biomedicine, tumour heterogeneity, the tumour microenvironment, digital tissue twins, tumorigenesis, clinical discovery, clinical forecasting
Deadlines: Travel Grant application deadline: 18 January 2027 Abstract submission deadline: 18 January 2027 Registration deadline: 15 February 2027
Key dates
Add registration closes to calendar
Add the conference to calendar
Closing dates are Anywhere on Earth (AoE) unless the organizer stated otherwise.
Venue
Viale Papa Giovanni XXIII, 106 24121 Bergamo Italy
Bergamo, Italy
Open Centro Congressi Giovanni XXIII in maps ↗The address is as the organizer gave it, and it is not checked against a map.
Similar conferences
Health & Medicine · Oncology
Global Summit on Cancer Research and Novel Drug Development
Health & Medicine · Oncology
Global Summit on Cancer Research and Novel Drug Development

Health & Medicine · Oncology


